| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |